A double-blind randomised controlled clinical trial of levosimendan vs dopexamine in septic shock

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN46862968

Enrollment

Registered

2006-09-29

Start date

2004-12-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Signs and Symptoms: Sepsis Signs and Symptoms Sepsis

Interventions

Randomised controlled trial (pilot study) with randomisation into two groups, double blinded to minimise researcher bias, patients randomised to levosimendan or dopexamine, the randomisation code to b

Eligibility

Inclusion criteria

Inclusion criteria: Not provided at time of registration

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Not provided at time of registration	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026